| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.0M | +24.4% | +57.1% |
| SG&A Expense | $3.2M | +26.4% | +88.8% |
| Operating Income | -$5.2M | -25.6% | -74.9% |
| Pre-tax Income | -$4.1M | -16.4% | -54.3% |
| Income Tax | $0 | — | — |
| Net Income | -$4.1M | -16.4% | -54.3% |
| EPS (Diluted) | -$0.16 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $154.6M | +57.2% | +471.9% |
| Total Assets | $155.1M | +56.7% | +461.4% |
| Current Liabilities | $1.6M | +30.6% | +34.5% |
| Stockholders' Equity | $153.5M | +57.0% | +480.1% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.1M | — | — |
| Investing Cash Flow | -$6K | — | — |
| Financing Cash Flow | $121.5M | — | — |
| +15.8% |